ABL1 and acute lymphoblastic leukemia: In the present study, we used the previously described BCR-ABL+ ALL cell line BV173 and patient-derived ALL xenografts (PDX) with stable luciferase expression, which allows non-invasive BLI to be used to visualize the leukemic burden in NSG mice (Figure 1a and Figure S1a) [9].